scholarly journals Two Cases of Strictures after Percutaneous CT-Guided Radiofrequency Ablation for Renal Cell Carcinoma

2020 ◽  
Vol 2020 ◽  
pp. 1-7
Author(s):  
Ortwin Heißler ◽  
Stephan Seklehner ◽  
Maximilian Fingernagel ◽  
Paul F. Engelhardt ◽  
Claus Riedl

Percutaneous radiofrequency ablation is a safe and effective minimally invasive treatment option in selected patients with T1a tumors of the kidney with a low complication rate. We describe two cases that developed the rare but severe complication of thermal injury-induced strictures of the upper urinary tract and its consecutive management.

2005 ◽  
Vol 46 (2) ◽  
pp. 208-214 ◽  
Author(s):  
A. H. Mahnken ◽  
D. Rohde ◽  
D. Brkovic ◽  
R. W. Günther ◽  
J. A. Tacke

Purpose: To report early results in percutaneous radiofrequency ablation (RFA) of renal cell carcinoma with an expandable RF probe. Material and Methods: In 14 patients (9 male, mean age 67.9±9.9 years) CT‐guided percutaneous radiofrequency ablation of 15 renal cell carcinomas was performed using an expandable LeVeen probe (diameter 2–4 cm) and a 200‐watt generator under general anesthesia and CT control. Tumors exceeding a diameter of 3 cm ( n = 6) were embolized within 24 h prior to RFA. Average tumor size was 3.0±1.0 cm. Results: RFA was technically successful in all patients, resulting in a mean size of necrosis of 3.7±0.7 cm. With the exception of one reno‐cutaneous fistula, which was successfully treated conservatively, no major complications were observed. No local recurrence was observed (follow‐up: 13.9±12.4 months) while extrarenal tumor progression occurred in four patients. Conclusion: Our preliminary data suggest that nephron sparing percutaneous RFA of renal tumors with an expandable RF probe is safe and effective.


2021 ◽  
pp. 112070002199626
Author(s):  
Oliver Eberhardt ◽  
Thekla von Kalle ◽  
Rebecca Matthis ◽  
Richard Doepner ◽  
Thomas Wirth ◽  
...  

Introduction: It is often difficult to clinically and radiologically diagnose intra-articular osteoid osteomas and osteoid osteomas of the hip joint. Treatment can also be difficult due to complex locational relationships. CT-guided radiofrequency ablation is currently the standard form of treatment. In this paper we report on a minimally-invasive concept for treating osteoid osteomas near the hip joint in children and adolescents which does not involve using computed tomography. Material and method: 10 patients with an average age of 12.1 years underwent treatment for osteoid osteomas in the hip joint region. The diagnosis was made using a contrast-enhanced MRI. The osteoid osteomas were marked percutaneously using x-ray and MRI guidance. MRI-guided drilling/curettage was performed in 4 cases and arthroscopic resection in 6 cases. Results: All lesions were successfully treated using the MRI-guided method. All patients were free of pain after the treatment. There was no instance of recurrence during the follow-up period, which averaged 10 months. The effective dose for marking the lesion was between 0.0186 mSv and 0.342 mSV (mean 0.084 mSV). Conclusions: Our MRI diagnostics protocol, the MRI-guided drilling and the minimally invasive hip arthroscopy represent an alternative to CT-guided radiofrequency ablation in the treatment of osteoid osteomas. Radiation exposure can thereby be significantly reduced. Hip arthroscopy can also be used to treat secondary pathologies such as femoroacetabular impingement.


Sign in / Sign up

Export Citation Format

Share Document